Novo Growth led a $25.7m round for The Protein Brewery, which is seeking regulatory clearance for its fermentation-based vegetarian protein ingredients.
The Protein Brewery, a Netherlands-based developer of animal-free protein ingredients, secured €22m ($25.7m) on Tuesday in a series A round led by pharmaceutical firm Novo through its Novo Growth subsidiary.
Roquette Ventures, the investment arm of plant-based ingredients producer Roquette, also took part in the round, as did alternative protein-focused investment firm Unovis Asset Management.
Founded in January this year when it was split off from industrial biotechnology producer BioscienZ, The Protein Brewery is using microbial fermentation technology to develop…
